Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials (Q37214309)
Jump to navigation
Jump to search
scientific article published on 10 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials |
scientific article published on 10 September 2013 |
Statements
1 reference
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials (English)
1 reference
A L Cesne
1 reference
I Judson
1 reference
F Grosso
1 reference
S Schuetze
1 reference
M V Mehren
1 reference
S P Chawla
1 reference
G D Demetri
1 reference
A Nieto
1 reference
A Tanovic
1 reference
10 September 2013
1 reference
1 reference
1717-1724
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference